Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Shapiro

Showing results (271-280 of 316) with videos related to

Pageof 32
Sort By:
Journal of the American Academy of Dermatology|March 12, 2022
Dermatologist awareness of scalp cooling for chemotherapy-induced alopeciaLu Yin, Elizabeth J Klein, Katerina Svigos, et al.
International Journal of Dermatology|April 17, 2026
Platelet-Rich Plasma Injections and Scalp Cutaneous Malignancies: Clinical Implications and Knowledge GapsArchie Spindler, Derek Maas, Isabella Zappi, et al.
Breast Cancer Research and Treatment|November 21, 2025
Adverse effects of scalp cooling for the reduction of chemotherapy-induced alopecia: A systematic review and meta-analysisCaitlin A Kearney, Anna L Brinks, Carli D Needle, et al.
Journal of the American Academy of Dermatology|November 13, 2017
Objective outcome measures: Collecting meaningful data on alopecia areataElise A Olsen, Janet Roberts, Leonard Sperling, et al.
The British Journal of Dermatology|September 14, 2023
When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trialsBrett King, Jerry Shapiro, Manabu Ohyama, et al.
The British Journal of Dermatology|October 21, 2024
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areataMelissa Piliang, Jennifer Soung, Brett King, et al.
Journal of the American Academy of Dermatology|October 8, 2025
Investigating barriers to systemic Janus kinase inhibitor access for alopecia areataCarli D Needle, Anna L Brinks, Nnaemeka Anyanwu, et al.
Journal of the American Academy of Dermatology|November 20, 2025
Beyond the surface: Histopathologic inflammation persists in many patients with clinically quiescent primary cicatricial alopeciaAnna Brinks, Carli Needle, Kaitlyn Yin, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2021
COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia PatientsKatharina S Shaw, Lu Yin, Jinal K Shah, et al.
Medical Hypotheses|December 14, 2020
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine boosterAndy Goren, Flavio Adsuara Cadegiani, Carlos Gustavo Wambier, et al.
Pageof 32

Showing results (271-280 of 316) with videos related to

Sort By:
Pageof 32
Journal of the American Academy of Dermatology|March 12, 2022
Dermatologist awareness of scalp cooling for chemotherapy-induced alopeciaLu Yin, Elizabeth J Klein, Katerina Svigos, et al.
International Journal of Dermatology|April 17, 2026
Platelet-Rich Plasma Injections and Scalp Cutaneous Malignancies: Clinical Implications and Knowledge GapsArchie Spindler, Derek Maas, Isabella Zappi, et al.
Breast Cancer Research and Treatment|November 21, 2025
Adverse effects of scalp cooling for the reduction of chemotherapy-induced alopecia: A systematic review and meta-analysisCaitlin A Kearney, Anna L Brinks, Carli D Needle, et al.
Journal of the American Academy of Dermatology|November 13, 2017
Objective outcome measures: Collecting meaningful data on alopecia areataElise A Olsen, Janet Roberts, Leonard Sperling, et al.
The British Journal of Dermatology|September 14, 2023
When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trialsBrett King, Jerry Shapiro, Manabu Ohyama, et al.
The British Journal of Dermatology|October 21, 2024
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areataMelissa Piliang, Jennifer Soung, Brett King, et al.
Journal of the American Academy of Dermatology|October 8, 2025
Investigating barriers to systemic Janus kinase inhibitor access for alopecia areataCarli D Needle, Anna L Brinks, Nnaemeka Anyanwu, et al.
Journal of the American Academy of Dermatology|November 20, 2025
Beyond the surface: Histopathologic inflammation persists in many patients with clinically quiescent primary cicatricial alopeciaAnna Brinks, Carli Needle, Kaitlyn Yin, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2021
COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia PatientsKatharina S Shaw, Lu Yin, Jinal K Shah, et al.
Medical Hypotheses|December 14, 2020
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine boosterAndy Goren, Flavio Adsuara Cadegiani, Carlos Gustavo Wambier, et al.
Pageof 32